Does Insulin Glargine Increase the Risk of Cancer Compared With Other Basal Insulins?: A French nationwide cohort study based on national administrative databases

OBJECTIVE: To explore in France the relationship between insulin glargine use and overall and specific cancer risks in type 2 diabetic patients compared with other basal insulins. RESEARCH DESIGN AND METHODS: Data were extracted from French health insurance information system (Système National d...

Descripción completa

Detalles Bibliográficos
Autores principales: Fagot, Jean-Paul, Blotière, Pierre-Olivier, Ricordeau, Philippe, Weill, Alain, Alla, François, Allemand, Hubert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554310/
https://www.ncbi.nlm.nih.gov/pubmed/22966091
http://dx.doi.org/10.2337/dc12-0506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554310/
https://www.ncbi.nlm.nih.gov/pubmed/22966091
http://dx.doi.org/10.2337/dc12-0506

Ejemplares similares